BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26580974)

  • 21. DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA.
    Tang L; Sheraz M; McGrane M; Chang J; Guo JT
    PLoS Pathog; 2019 Apr; 15(4):e1007742. PubMed ID: 31026293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon Alpha Induces Multiple Cellular Proteins That Coordinately Suppress Hepadnaviral Covalently Closed Circular DNA Transcription.
    Cheng J; Zhao Q; Zhou Y; Tang L; Sheraz M; Chang J; Guo JT
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation profile of hepatitis B virus is not influenced by interferon α in human liver cancer cells.
    Moon IY; Kim JW
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
    Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome.
    Belloni L; Allweiss L; Guerrieri F; Pediconi N; Volz T; Pollicino T; Petersen J; Raimondo G; Dandri M; Levrero M
    J Clin Invest; 2012 Feb; 122(2):529-37. PubMed ID: 22251702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of cccDNA function in hepatitis B virus infection.
    Levrero M; Pollicino T; Petersen J; Belloni L; Raimondo G; Dandri M
    J Hepatol; 2009 Sep; 51(3):581-92. PubMed ID: 19616338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
    Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
    Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.
    Yan Z; Zeng J; Yu Y; Xiang K; Hu H; Zhou X; Gu L; Wang L; Zhao J; Young JAT; Gao L
    J Hepatol; 2017 Jun; 66(6):1149-1157. PubMed ID: 28213165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription.
    Yu X; Long Q; Shen S; Liu Z; Chandran J; Zhang J; Ding H; Zhang H; Cai D; Kim ES; Huang Y; Guo H
    Antiviral Res; 2023 Mar; 211():105552. PubMed ID: 36737008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of hepatitis B core protein in HBV transcription and recruitment of histone acetyltransferases to cccDNA minichromosome.
    Chong CK; Cheng CYS; Tsoi SYJ; Huang FY; Liu F; Seto WK; Lai CL; Yuen MF; Wong DK
    Antiviral Res; 2017 Aug; 144():1-7. PubMed ID: 28499864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic manners.
    Xu L; Wu Z; Tan S; Wang Z; Lin Q; Li X; Song X; Liu Y; Song Y; Zhang J; Peng J; Gao L; Gong Y; Liang X; Zuo X; Ma C
    Antiviral Res; 2018 May; 153():114-123. PubMed ID: 29580980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIRT7 restricts HBV transcription and replication through catalyzing desuccinylation of histone H3 associated with cccDNA minichromosome.
    Yu HB; Cheng ST; Ren F; Chen Y; Shi XF; Wong VKW; Law BYK; Ren JH; Zhong S; Chen WX; Xu HM; Zhang ZZ; Hu JL; Cai XF; Hu Y; Zhang WL; Long QX; He L; Hu ZW; Jiang H; Zhou HZ; Huang AL; Chen J
    Clin Sci (Lond); 2021 Jun; 135(12):1505-1522. PubMed ID: 34128977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-α inhibits HBV transcription and replication by promoting HDAC3-mediated de-2-hydroxyisobutyrylation of histone H4K8 on HBV cccDNA minichromosome in liver.
    Zhao LN; Yuan HF; Wang YF; Yun HL; Zheng W; Yuan Y; Geng Y; Zhao M; Feng LY; Zhang XD
    Acta Pharmacol Sin; 2022 Jun; 43(6):1484-1494. PubMed ID: 34497374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.
    Zhong Y; Wu C; Xu Z; Teng Y; Zhao L; Zhao K; Wang J; Wang W; Zhan Q; Zhu C; Chen X; Liang K; Cheng X; Xia Y
    J Virol; 2022 Nov; 96(21):e0136222. PubMed ID: 36226986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner.
    Saeed U; Kim J; Piracha ZZ; Kwon H; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.
    Belloni L; Pollicino T; De Nicola F; Guerrieri F; Raffa G; Fanciulli M; Raimondo G; Levrero M
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19975-9. PubMed ID: 19906987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.
    Nassal M
    Gut; 2015 Dec; 64(12):1972-84. PubMed ID: 26048673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?
    Schreiner S; Nassal M
    Viruses; 2017 May; 9(5):. PubMed ID: 28531167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.
    Cheng ST; Hu JL; Ren JH; Yu HB; Zhong S; Wai Wong VK; Kwan Law BY; Chen WX; Xu HM; Zhang ZZ; Cai XF; Hu Y; Zhang WL; Long QX; Ren F; Zhou HZ; Huang AL; Chen J
    J Hepatol; 2021 Mar; 74(3):522-534. PubMed ID: 32987030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.